A citation-based method for searching scientific literature

Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal, Børge G Nordestgaard, Carl E Orringer. J Clin Lipidol 2019
Times Cited: 154







List of co-cited articles
1190 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
61

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.
Sotirios Tsimikas, Ewa Karwatowska-Prokopczuk, Ioanna Gouni-Berthold, Jean-Claude Tardif, Seth J Baum, Elizabeth Steinhagen-Thiessen, Michael D Shapiro, Erik S Stroes, Patrick M Moriarty, Børge G Nordestgaard,[...]. N Engl J Med 2020
259
51

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Robert Clarke, John F Peden, Jemma C Hopewell, Theodosios Kyriakou, Anuj Goel, Simon C Heath, Sarah Parish, Simona Barlera, Maria Grazia Franzosi, Stephan Rust,[...]. N Engl J Med 2009
873
40

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Michelle L O'Donoghue, Sergio Fazio, Robert P Giugliano, Erik S G Stroes, Estella Kanevsky, Ioanna Gouni-Berthold, KyungAh Im, Armando Lira Pineda, Scott M Wasserman, Richard Češka,[...]. Circulation 2019
282
39

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
Sebhat Erqou, Stephen Kaptoge, Philip L Perry, Emanuele Di Angelantonio, Alexander Thompson, Ian R White, Santica M Marcovina, Rory Collins, Simon G Thompson, John Danesh. JAMA 2009
963
37

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
Vera A Bittner, Michael Szarek, Philip E Aylward, Deepak L Bhatt, Rafael Diaz, Jay M Edelberg, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Corinne Hanotin,[...]. J Am Coll Cardiol 2020
147
36

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
Pia R Kamstrup, Anne Tybjaerg-Hansen, Rolf Steffensen, Børge G Nordestgaard. JAMA 2009
747
36


Lipoprotein(a) as a cardiovascular risk factor: current status.
Børge G Nordestgaard, M John Chapman, Kausik Ray, Jan Borén, Felicita Andreotti, Gerald F Watts, Henry Ginsberg, Pierre Amarenco, Alberico Catapano, Olivier S Descamps,[...]. Eur Heart J 2010
33

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Stephen Burgess, Brian A Ference, James R Staley, Daniel F Freitag, Amy M Mason, Sune F Nielsen, Peter Willeit, Robin Young, Praveen Surendran, Savita Karthikeyan,[...]. JAMA Cardiol 2018
235
31


Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.
Peter Willeit, Paul M Ridker, Paul J Nestel, John Simes, Andrew M Tonkin, Terje R Pedersen, Gregory G Schwartz, Anders G Olsson, Helen M Colhoun, Florian Kronenberg,[...]. Lancet 2018
206
29

HEART UK consensus statement on Lipoprotein(a): A call to action.
Jaimini Cegla, R Dermot G Neely, Michael France, Gordon Ferns, Chris D Byrne, Julian Halcox, Dev Datta, Nigel Capps, Carol Shoulders, Nadeem Qureshi,[...]. Atherosclerosis 2019
57
49

Lipoprotein (a) measurements for clinical application.
Santica M Marcovina, John J Albers. J Lipid Res 2016
142
28

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.
Sotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, Henry N Ginsberg, Marlys L Koschinsky, Santica M Marcovina, Patrick M Moriarty, Daniel J Rader, Alan T Remaley, Gissette Reyes-Soffer,[...]. J Am Coll Cardiol 2018
198
26

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
968
25

Statin therapy increases lipoprotein(a) levels.
Sotirios Tsimikas, Philip L S M Gordts, Chelsea Nora, Calvin Yeang, Joseph L Witztum. Eur Heart J 2020
128
25

Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.
Christian M Madsen, Pia R Kamstrup, Anne Langsted, Anette Varbo, Børge G Nordestgaard. Arterioscler Thromb Vasc Biol 2020
62
38

Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
Pia R Kamstrup, Anne Tybjærg-Hansen, Børge G Nordestgaard. J Am Coll Cardiol 2014
293
23

Elevated Lipoprotein(a) and Risk of Ischemic Stroke.
Anne Langsted, Børge G Nordestgaard, Pia R Kamstrup. J Am Coll Cardiol 2019
62
37

Genetic associations with valvular calcification and aortic stenosis.
George Thanassoulis, Catherine Y Campbell, David S Owens, J Gustav Smith, Albert V Smith, Gina M Peloso, Kathleen F Kerr, Sonali Pechlivanis, Matthew J Budoff, Tamara B Harris,[...]. N Engl J Med 2013
548
21

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
21

Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.
Guillaume Paré, Artuela Çaku, Matthew McQueen, Sonia S Anand, Enas Enas, Robert Clarke, Michael B Boffa, Marlys Koschinsky, Xingyu Wang, Salim Yusuf. Circulation 2019
98
21

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.
Michael Szarek, Vera A Bittner, Philip Aylward, Marie Baccara-Dinet, Deepak L Bhatt, Rafael Diaz, Zlatko Fras, Shaun G Goodman, Sigrun Halvorsen, Robert A Harrington,[...]. Eur Heart J 2020
50
42

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials.
Nicholas J Viney, Julian C van Capelleveen, Richard S Geary, Shuting Xia, Joseph A Tami, Rosie Z Yu, Santica M Marcovina, Steven G Hughes, Mark J Graham, Rosanne M Crooke,[...]. Lancet 2016
412
20


Structure, function, and genetics of lipoprotein (a).
Konrad Schmidt, Asma Noureen, Florian Kronenberg, Gerd Utermann. J Lipid Res 2016
186
19

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
Katrina L Ellis, Leopoldo Pérez de Isla, Rodrigo Alonso, Francisco Fuentes, Gerald F Watts, Pedro Mata. J Am Coll Cardiol 2019
57
31

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
17

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. J Am Coll Cardiol 2019
911
17

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.
Eberhard Roeseler, Ulrich Julius, Franz Heigl, Ralf Spitthoever, Dennis Heutling, Paul Breitenberger, Josef Leebmann, Walter Lehmacher, Pia R Kamstrup, Børge G Nordestgaard,[...]. Arterioscler Thromb Vasc Biol 2016
114
17

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.
Sotirios Tsimikas, Nicholas J Viney, Steven G Hughes, Walter Singleton, Mark J Graham, Brenda F Baker, Jennifer L Burkey, Qingqing Yang, Santica M Marcovina, Richard S Geary,[...]. Lancet 2015
301
16


High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
Anne Langsted, Pia R Kamstrup, Marianne Benn, Anne Tybjærg-Hansen, Børge G Nordestgaard. Lancet Diabetes Endocrinol 2016
148
15

A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.
K BERG. Acta Pathol Microbiol Scand 1963
15

Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.
Pia R Kamstrup, Marianne Benn, Anne Tybjaerg-Hansen, Børge G Nordestgaard. Circulation 2008
292
15

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
15

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
Romain Capoulade, Kwan L Chan, Calvin Yeang, Patrick Mathieu, Yohan Bossé, Jean G Dumesnil, James W Tam, Koon K Teo, Ablajan Mahmut, Xiaohong Yang,[...]. J Am Coll Cardiol 2015
203
14

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
Kang H Zheng, Sotirios Tsimikas, Tania Pawade, Jeffrey Kroon, William S A Jenkins, Mhairi K Doris, Audrey C White, Nyanza K L M Timmers, Jesper Hjortnaes, Maximillian A Rogers,[...]. J Am Coll Cardiol 2019
101
14

Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.
Salim S Virani, Ariel Brautbar, Brian C Davis, Vijay Nambi, Ron C Hoogeveen, A Richey Sharrett, Josef Coresh, Thomas H Mosley, Joel D Morrisett, Diane J Catellier,[...]. Circulation 2012
159
14

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
William E Boden, Jeffrey L Probstfield, Todd Anderson, Bernard R Chaitman, Patrice Desvignes-Nickens, Kent Koprowicz, Ruth McBride, Koon Teo, William Weintraub. N Engl J Med 2011
13

Effects of extended-release niacin with laropiprant in high-risk patients.
Martin J Landray, Richard Haynes, Jemma C Hopewell, Sarah Parish, Theingi Aung, Joseph Tomson, Karl Wallendszus, Martin Craig, Lixin Jiang, Rory Collins,[...]. N Engl J Med 2014
989
13

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
Weihua Guan, Jing Cao, Brian T Steffen, Wendy S Post, James H Stein, Mathew C Tattersall, Joel D Kaufman, Joseph P McConnell, Daniel M Hoefner, Russell Warnick,[...]. Arterioscler Thromb Vasc Biol 2015
85
15

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
Todd J Anderson, Jean Grégoire, Glen J Pearson, Arden R Barry, Patrick Couture, Martin Dawes, Gordon A Francis, Jacques Genest, Steven Grover, Milan Gupta,[...]. Can J Cardiol 2016
520
13

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Børge G Nordestgaard, M John Chapman, Steve E Humphries, Henry N Ginsberg, Luis Masana, Olivier S Descamps, Olov Wiklund, Robert A Hegele, Frederick J Raal, Joep C Defesche,[...]. Eur Heart J 2013
13


Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
Rodrigo Alonso, Eduardo Andres, Nelva Mata, Francisco Fuentes-Jiménez, Lina Badimón, José López-Miranda, Teresa Padró, Ovidio Muñiz, Jose Luis Díaz-Díaz, Marta Mauri,[...]. J Am Coll Cardiol 2014
209
12

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
Daniel F Gudbjartsson, Gudmundur Thorgeirsson, Patrick Sulem, Anna Helgadottir, Arnaldur Gylfason, Jona Saemundsdottir, Eythor Bjornsson, Gudmundur L Norddahl, Aslaug Jonasdottir, Adalbjorg Jonasdottir,[...]. J Am Coll Cardiol 2019
63
19

Lipoprotein (a): impact by ethnicity and environmental and medical conditions.
Byambaa Enkhmaa, Erdembileg Anuurad, Lars Berglund. J Lipid Res 2016
79
15

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.
Fleur M van der Valk, Siroon Bekkering, Jeffrey Kroon, Calvin Yeang, Jan Van den Bossche, Jaap D van Buul, Amir Ravandi, Aart J Nederveen, Hein J Verberne, Corey Scipione,[...]. Circulation 2016
243
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.